Literature DB >> 19559712

Structure of the murine unglycosylated IgG1 Fc fragment.

Matthias J Feige1, Susanne Nath, Silvia R Catharino, Daniel Weinfurtner, Stefan Steinbacher, Johannes Buchner.   

Abstract

A prototypic IgG antibody can be divided into two major structural units: the antigen-binding fragment (Fab) and the Fc fragment that mediates effector functions. The IgG Fc fragment is a homodimer of the two C-terminal domains (C(H)2 and C(H)3) of the heavy chains. Characteristic of the Fc part is the presence of a sugar moiety at the inner face of the C(H)2 domains. The structure of this complex branched oligosaccharide is generally resolved in crystal structures of Fc fragments due to numerous well-defined sugar-protein interactions and a small number of sugar-sugar interactions. This suggested that sugars play an important role in the structure of the Fc fragment. To address this question directly, we determined the crystal structure of the unglycosylated Fc fragment of the murine IgG1 MAK33. The structures of the C(H)3 domains of the unglycosylated Fc fragment superimpose perfectly with the structure of the isolated MAK33 C(H)3 domain. The unglycosylated C(H)2 domains, in contrast, approach each other much more closely compared to known structures of partly deglycosylated Fc fragments with rigid-body motions between 10 and 14 A, leading to a strongly "closed" conformation of the unglycosylated Fc fragment. The glycosylation sites in the C'E loop and the BC and FG loops are well defined in the unglycosylated C(H)2 domain, however, with increased mobility and with a significant displacement of about 4.9 A for the unglycosylated Asn residue compared to the glycosylated structure. Thus, glycosylation both stabilizes the C'E-loop conformation within the C(H)2 domain and also helps to ensure an "open" conformation, as seen upon Fc receptor binding. These structural data provide a rationale for the observation that deglycosylation of antibodies often compromises their ability to bind and activate Fcgamma receptors.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19559712     DOI: 10.1016/j.jmb.2009.06.048

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  34 in total

1.  Crystal structure of Fcγ receptor I and its implication in high affinity γ-immunoglobulin binding.

Authors:  Jinghua Lu; Jeff L Ellsworth; Nels Hamacher; Si Won Oak; Peter D Sun
Journal:  J Biol Chem       Date:  2011-09-29       Impact factor: 5.157

2.  Advanced analyses of kinetic stabilities of iggs modified by mutations and glycosylation.

Authors:  Erik Sedlák; Jonas V Schaefer; Jozef Marek; Peter Gimeson; Andreas Plückthun
Journal:  Protein Sci       Date:  2015-06-11       Impact factor: 6.725

3.  Structure of FcγRI in complex with Fc reveals the importance of glycan recognition for high-affinity IgG binding.

Authors:  Jinghua Lu; Jonathan Chu; Zhongcheng Zou; Nels B Hamacher; Mark W Rixon; Peter D Sun
Journal:  Proc Natl Acad Sci U S A       Date:  2015-01-05       Impact factor: 11.205

Review 4.  Targeting B cells and autoantibodies in the therapy of autoimmune diseases.

Authors:  Daniela Kao; Anja Lux; Inessa Schwab; Falk Nimmerjahn
Journal:  Semin Immunopathol       Date:  2014-04-29       Impact factor: 9.623

5.  Binding structures and energies of the human neonatal Fc receptor with human Fc and its mutants by molecular modeling and dynamics simulations.

Authors:  Xiaoqin Huang; Fang Zheng; Chang-Guo Zhan
Journal:  Mol Biosyst       Date:  2013-09-20

6.  In vivo imaging reveals a tumor-associated macrophage-mediated resistance pathway in anti-PD-1 therapy.

Authors:  Sean P Arlauckas; Christopher S Garris; Rainer H Kohler; Maya Kitaoka; Michael F Cuccarese; Katherine S Yang; Miles A Miller; Jonathan C Carlson; Gordon J Freeman; Robert M Anthony; Ralph Weissleder; Mikael J Pittet
Journal:  Sci Transl Med       Date:  2017-05-10       Impact factor: 17.956

Review 7.  With or without sugar? (A)glycosylation of therapeutic antibodies.

Authors:  Dmitrij Hristodorov; Rainer Fischer; Lars Linden
Journal:  Mol Biotechnol       Date:  2013-07       Impact factor: 2.695

8.  Revisiting the role of glycosylation in the structure of human IgG Fc.

Authors:  M Jack Borrok; Sang Taek Jung; Tae Hyun Kang; Arthur F Monzingo; George Georgiou
Journal:  ACS Chem Biol       Date:  2012-07-10       Impact factor: 5.100

9.  The Structural Role of Antibody N-Glycosylation in Receptor Interactions.

Authors:  Ganesh P Subedi; Adam W Barb
Journal:  Structure       Date:  2015-07-23       Impact factor: 5.006

10.  Structural characterization of anti-inflammatory immunoglobulin G Fc proteins.

Authors:  Alysia A Ahmed; John Giddens; Andrew Pincetic; Joseph V Lomino; Jeffrey V Ravetch; Lai-Xi Wang; Pamela J Bjorkman
Journal:  J Mol Biol       Date:  2014-07-15       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.